| Literature DB >> 26434690 |
Revati K Phalkey1,2, Mareike Kroll1, Sayani Dutta3, Sharvari Shukla4, Carsten Butsch1, Erach Bharucha3, Frauke Kraas1.
Abstract
BACKGROUND: Participation of private practitioners in routine disease surveillance in India is minimal despite the fact that they account for over 70% of the primary healthcare provision. We aimed to investigate the knowledge, attitudes, and practices of private practitioners in the city of Pune toward disease surveillance. Our goal was to identify what barriers and facilitators determine their participation in current and future surveillance efforts.Entities:
Keywords: barriers and facilitators; disease surveillance; knowledge-attitude-practice; private practitioners
Mesh:
Year: 2015 PMID: 26434690 PMCID: PMC4592845 DOI: 10.3402/gha.v8.28413
Source DB: PubMed Journal: Glob Health Action ISSN: 1654-9880 Impact factor: 2.640
General characteristics of the respondents (n, %)
| Allopathy (59) | Ayurveda and Unani (114) | Homeopathy (85) | Total ( | ||
|---|---|---|---|---|---|
| Location | Inner city ward | 32 (54) | 48 (42) | 27 (32) | 107 (41) |
| Urban fringe ward | 21 (36) | 57 (50) | 50 (59) | 128 (50) | |
| Suburban fringe area | 6 (10) | 9 (8) | 8 (9) | 23 (9) | |
| Gender | Male | 45 (76) | 82 (72) | 57 (67) | 184 (71) |
| Female | 14 (24) | 32 (28) | 28 (33) | 74 (29) | |
| Qualification | Graduate | 29 (49) | 96 (83) | 67 (79) | 192 (74) |
| Postgraduate | 30 (51) | 18 (16) | 18 (21) | 66 (26) | |
| Duration of practice | Total mean (SD) | 23.1 (12.4) | 14.3 (11.2) | 12.0 (8.3) | 15.4 (11.4) |
| Inner city ward | 28.1 (10.4) | 18.4 (13.2) | 15.3 (9.2) | 20.4 (12.5) | |
| Urban fringe ward | 17.1 (12.4) | 10.6 (7.8) | 10.6 (7.5) | 11.7 (8.9) | |
| Suburban fringe area | 19.2 (12.4) | 12.2 (11.0) | 9.1 (7.1) | 12.9 (10.6) | |
| Patients/day | Mean (SD) | 25 (25) | 22 (17) | 12 (8) | 15 (11) |
| Catchment area | Majority same ward | 32 (54) | 78 (68) | 58 (68) | 168 (65) |
Surveillance capacities among respondents (n, %)
| Allopathy (59) | Ayurveda and Unani (114) | Homeopathy (85) | Total ( | |
|---|---|---|---|---|
| Logistics and equipment | ||||
| Electricity backup | 43 (75) | 51 (45) | 40 (49) | 134 (54) |
| Computer | 27 (46) | 44 (38) | 30 (36) | 101 (39) |
| Internet | 28 (48) | 48 (42) | 39 (46) | 115 (45) |
| Maintain minimum data (age, gender, diagnosis, test results) | 16 (27) | 19 (17) | 24 (28) | 59 (23) |
| Human resources | ||||
| Receptionist | 42 (71) | 38 (33) | 27 (32) | 107 (41) |
| Paramedic | 21 (36) | 24 (21) | 10 (12) | 55 (21) |
| Diagnostic and treatment infrastructure | ||||
| X-ray | 9 (15) | 5 (4) | 6 (16) | 20 (15) |
| ECG | 21 (36) | 21 (18) | 17 (45) | 59 (46) |
| USG | 4 (7) | 3 (3) | 2 (5) | 9 (7) |
| Laboratory | 13 (22) | 13 (11) | 11 (13) | 37 (14) |
| Spirometry | 8 (14) | 6 (5) | 1 (1) | 15 (6) |
| Rapid diagnostic tests | 33 (56) | 36 (3) | 25 (29) | 94 (36) |
| In-patient admission | 19 (32) | 18 (16) | 16 (19) | 53 (20) |
Diagnostic and treatment practices (n, %)
| Allopathy (59) | Ayurveda and Unani (114) | Homeopathy (85) | Total ( | ||
|---|---|---|---|---|---|
| Diabetes | Diagnosis | 58 (98) | 109 (96) | 78 (92) | 245 (95) |
| Laboratory confirmation | 52 (90) | 99 (91) | 73 (94) | 224 (91) | |
| Treatment in clinic | 45 (78) | 58 (53) | 46 (59) | 149 (61) | |
| Cardiovascular diseases | Diagnosis | 55 (93) | 107 (94) | 75 (88) | 237 (92) |
| Laboratory confirmation | 44 (80) | 73 (68) | 55 (73) | 172 (73) | |
| Treatment in clinic | 40 (73) | 50 (47) | 40 (53) | 130 (55) | |
| Chronic respiratory diseases | Diagnosis | 53 (90) | 105 (92) | 76 (89) | 234 (91) |
| Laboratory confirmation | 40 (75) | 72 (69) | 53 (70) | 165 (71) | |
| Treatment in clinic | 43 (81) | 63 (60) | 50 (66) | 156 (67) | |
| Cancers | Diagnosis | 39 (66) | 52 (46) | 44 (52) | 135 (52) |
| Laboratory confirmation | 26 (67) | 21 (40) | 22 (50) | 69 (51) | |
| Treatment in clinic | 7 (18) | 10 (19) | 11 (25) | 28 (21) | |
| Tuberculosis | Diagnosis | 53 (90) | 76 (76) | 60 (71) | 189 (73) |
| Laboratory confirmation | 45 (85) | 50 (66) | 53 (88) | 148 (78) | |
| Treatment in clinic | 38 (72) | 21 (28) | 18 (30) | 77 (41) | |
| Dengue | Diagnosis | 51 (86) | 84 (74) | 59 (69) | 194 (75) |
| Laboratory confirmation | 47 (92) | 59 (70) | 52 (88) | 158 (81) | |
| Treatment in clinic | 35 (69) | 38 (45) | 27 (46) | 100 (52) |
Knowledge and opinion regarding surveillance efforts (n, %)
| Allopathy (59) | Ayurveda and Unani (114) | Homeopathy (85) | Total ( | |
|---|---|---|---|---|
| Knowledge regarding disease surveillance | ||||
| Aware about disease surveillance | 39 (66) | 45 (39) | 37 (44) | 121 (47) |
| Surveillance components named by the practitioners | ||||
| Systematic collection of disease information | 25 (42) | 26 (23) | 20 (23) | 71 (27) |
| Analysis of disease information | 11 (19) | 13 (12) | 16 (19) | 40 (15) |
| Dissemination to allow action | 9 (15) | 13 (12) | 8 (9) | 30 (12) |
| Application of data for disease control | 24 (41) | 15 (13) | 12 (14) | 51 (20) |
| Able to name at least two national disease control programs | 25 (42) | 38 (33) | 31 (36) | 94 (36) |
| Opinion regarding surveillance efforts | ||||
| Current infectious disease burden is | 42 (71) | 61 (54) | 48 (57) | 151 (59) |
| Current NCD burden is | 44 (75) | 66 (58) | 50 (59) | 160 (62) |
| Disease surveillance is important for urban health | 54 (93) | 106 (93) | 80 (95) | 240 (94) |
NCD, non-communicable disease.
Barriers and facilitators for participation in regular surveillance (multiple answers possible) (n, %)
| Barriers ( | Facilitators ( | ||
|---|---|---|---|
| Intrinsic (individual/facility level) | |||
| Lack of time | 137 (55) | Monetary/infrastructural incentives | 33 (17) |
| Attitude: lack of motivation/routine | 23 (9) | Acknowledgment of efforts | 10 (5) |
| Lack of infrastructure (personal/equipment, etc.) | 14 (6) | Participation in research | 6 (3) |
| Patient interaction: follow-up with patient, data privacy | 11 (4) | ||
| Extrinsic (government level) | |||
| Poor cooperation government/private sector | 27 (11) | Information/awareness/training about surveillance | 78 (40) |
| Legal issues with alternate medicine | 15 (6) | Mandatory regulations | 30 (15) |
| Effective use of collected data | 11 (4) | Better reporting system | 25 (13) |
| Lack of clear guidelines for submitting data | 7 (3) | Others | 13 (7) |
| Others | 6 (2) | ||